gip/glp-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

Overall, given the relatively low usage of GLP-1 RAs in the UK and Europe, further clinical evidence and prescribing guidance may be beneficial to encourage the optimised use of GLP-1 RAs

They can also help type 1 diabetes patients lose weight, something thats especially difficult for people who take insulin, which signals the body to take extra sugar out of the blood and store it as fat

Earlier this year, animal research published in eBioMedicine (February 2026) added to a growing body of evidence suggesting that medications acting on the GLP-1 system may one day play a role in treating alcohol use disorder ( AUD )

After significant weight loss, the skin that once stretched to accommodate fullness may not contract fully

This can make you feel tired, weak, dizzy, or even lose muscle

WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management programs